These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

885 related items for PubMed ID: 30281385

  • 1. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Akbari R, Hakemi-Vala M, Pashaie F, Bevalian P, Hashemi A, Pooshang Bagheri K.
    Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
    [Abstract] [Full Text] [Related]

  • 2. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 3. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.
    Bardbari AM, Arabestani MR, Karami M, Keramat F, Aghazadeh H, Alikhani MY, Bagheri KP.
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):443-454. PubMed ID: 29353377
    [Abstract] [Full Text] [Related]

  • 4. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
    Jahangiri A, Neshani A, Mirhosseini SA, Ghazvini K, Zare H, Sedighian H.
    Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
    [Abstract] [Full Text] [Related]

  • 5. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of Pseudomonas aeruginosa.
    Mataraci Kara E, Yilmaz M, İstanbullu Tosun A, Özbek Çelik B.
    Infect Dis (Lond); 2020 Sep; 52(9):616-624. PubMed ID: 32427010
    [Abstract] [Full Text] [Related]

  • 6. Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Pankuch GA, Seifert H, Appelbaum PC.
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):191-7. PubMed ID: 20338710
    [Abstract] [Full Text] [Related]

  • 7. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.
    Mataracı Kara E, Yılmaz M, Özbek Çelik B.
    J Glob Antimicrob Resist; 2019 Jun; 17():137-141. PubMed ID: 30576787
    [Abstract] [Full Text] [Related]

  • 8. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC, Choi JA, Jang SJ, Jeong SH, Kim CM, Choi IS, Kang SH, Park G, Moon DS.
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [Abstract] [Full Text] [Related]

  • 9. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
    Deveci A, Coban AY, Acicbe O, Tanyel E, Yaman G, Durupinar B.
    J Chemother; 2012 Oct; 24(5):247-52. PubMed ID: 23182043
    [Abstract] [Full Text] [Related]

  • 10. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
    Farzi N, Oloomi M, Bahramali G, Siadat SD, Bouzari S.
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
    Somily AM, Absar MM, Arshad MZ, Al Aska AI, Shakoor ZA, Fatani AJ, Siddiqui YM, Murray TS.
    Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309
    [Abstract] [Full Text] [Related]

  • 13. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Konai MM, Haldar J.
    ACS Infect Dis; 2020 Jan 10; 6(1):91-99. PubMed ID: 31646866
    [Abstract] [Full Text] [Related]

  • 14. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M, Mataseje LF, Loo V, Walkty A, Adam HJ, Hoban DJ, Zhanel GG, Mulvey MR, Canadian Antimicrobial Resistance Alliance (CARA).
    Diagn Microbiol Infect Dis; 2011 Mar 10; 69(3):335-41. PubMed ID: 21353962
    [Abstract] [Full Text] [Related]

  • 15. Synergistic Effect of Tazobactam on Amikacin MIC in Acinetobacter baumannii Isolated from Burn Patients in Tehran, Iran.
    Azimi L, Tahbaz SV, Alaghehbandan R, Alinejad F, Lari AR.
    Curr Pharm Biotechnol; 2020 Mar 10; 21(10):997-1004. PubMed ID: 32077820
    [Abstract] [Full Text] [Related]

  • 16. Plasmid-mediated mcr-1 gene in Acinetobacter baumannii and Pseudomonas aeruginosa: first report from Pakistan.
    Hameed F, Khan MA, Muhammad H, Sarwar T, Bilal H, Rehman TU.
    Rev Soc Bras Med Trop; 2019 Sep 05; 52():e20190237. PubMed ID: 31508785
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey.
    Ece G, Samlioglu P, Atalay S, Kose S.
    Infez Med; 2014 Mar 05; 22(1):36-40. PubMed ID: 24651089
    [Abstract] [Full Text] [Related]

  • 19. Time-kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin.
    Safarika A, Galani I, Pistiki A, Giamarellos-Bourboulis EJ.
    Eur J Clin Microbiol Infect Dis; 2015 Feb 05; 34(2):317-23. PubMed ID: 25192733
    [Abstract] [Full Text] [Related]

  • 20. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan.
    Hsueh SC, Lee YJ, Huang YT, Liao CH, Tsuji M, Hsueh PR.
    J Antimicrob Chemother; 2019 Feb 01; 74(2):380-386. PubMed ID: 30357343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.